-

Nomi Health Opens New Testing Site to Serve Carteret County Community

Nomi invites local media and businesses to visit the site during open house on Monday, February 28th

MOREHEAD CITY, N.C.--(BUSINESS WIRE)--Nomi Health, the direct healthcare company providing easy-to-access COVID-19 testing to communities across the United States, has opened a new location in Morehead City, North Carolina:

Open Monday 2/28 10 AM: 3413 Bridges St., Morehead City, NC 28557
Hours of Operation: Monday - Sunday, 10AM-10PM

Demand for COVID-testing remains high in the region, according to an early-February update from the Carteret County Department of Human Services website1. Rapid PCR (30 minutes results) and Nasal PCR (24-36 hours results) tests are available at the new Nomi Health testing site starting today. While patients are asked to bring their insurance information, patients without insurance will not be turned away. Patients with questions can call the Nomi Health Call Center at (980) 206-5085. Appointments are not required, but pre-registration is available at https://mdc.nomihealth.com/signup/nc/BS.

Nomi Health will host an open house on Monday, February 28, 2022 for local media, businesses and organizations.

About Nomi Health

Nomi Health is a direct healthcare company focused on making healthcare actually work for those who buy it for their states, organizations, and constituents. We’re a team of over 2,000--each actively working to connect buyers and healthcare providers directly to lower costs, deliver care solutions to all and rewire the health system to run in real-time. From the front lines of COVID testing and vaccination serving over 10 million Americans and more than 40,000 patients each day, to building new ecosystems of buyers such as States and Counties without middlemen, Nomi delivers a solution for our nation’s leaders seeking to widen access to care while lowering cost of care. Visit us @NomiHealth and www.nomihealth.com.

_____________________________

1 https://www.carteretcountync.gov/DocumentCenter/View/9972/2022-02-02---News-Release---Expanded-opportunity-for-COVID-19-testing-in-Carteret-County

Contacts

Audrey Chittick
mPR, Inc. for Nomi Health
audrey@mpublicrelations.com

Industry:

Nomi Health

Release Summary
Nomi Health is opening a new COVID-19 testing site to serve the Carteret County community.
Release Versions
English

Contacts

Audrey Chittick
mPR, Inc. for Nomi Health
audrey@mpublicrelations.com

More News From Nomi Health

CerpassRx Launches AI Engine Powered By Waltz Health to Deliver Real-Time Savings and Spend Management for Specialty Drugs

DALLAS & CHICAGO--(BUSINESS WIRE)--CerpassRx, a leader in pharmacy benefit management (PBM), today announced the launch of the Intelligent Specialty Engine, an AI-enabled platform powered by Waltz Health to manage specialty drug spend. CerpassRx’s innovative approach includes real-time analytics and specialty spend management capabilities that drive significant cost savings, improve transparency and optimize the specialty drug experience for health plan customers and their members – or self-ins...

CareSource and Nomi Health Launch Innovative Partnership to Improve Healthcare Access and Outcomes

DAYTON, Ohio--(BUSINESS WIRE)--CareSource, a non-profit health plan with over 2 million members, has selected Nomi Health to partner with it in launching a new comprehensive effort to help close gaps in healthcare access and outcomes for its Medicaid members across Ohio, Georgia, and Indiana. This collaboration aims to enhance access to essential healthcare services and improve overall health outcomes for people facing barriers to care. "This partnership with Nomi Health represents a significan...

Weight Loss Drugs Weigh Heavy on Employer Health Plans

OREM, Utah--(BUSINESS WIRE)--A meteoric rise in the popularity of glucagon-like peptide-1 (GLP-1) medications such as Ozempic, Wegovy and Mounjaro is creating financial challenges for employer-sponsored health plans. New data from Nomi Health, a company changing healthcare economics, reveals that spending on these diabetes and weight loss drugs went up 253% from 2020 to 2023, surpassing $1 billion last year and making up nearly 10% of total prescription costs for employers. Nomi Health analyzed...
Back to Newsroom